These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17351621)

  • 1. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein.
    Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM
    Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation.
    van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW
    J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confocal fluorescence anisotropy and FRAP imaging of α-synuclein amyloid aggregates in living cells.
    Roberti MJ; Jovin TM; Jares-Erijman E
    PLoS One; 2011; 6(8):e23338. PubMed ID: 21858077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cells.
    Roberti MJ; Morgan M; Menéndez G; Pietrasanta LI; Jovin TM; Jares-Erijman EA
    J Am Chem Soc; 2009 Jun; 131(23):8102-7. PubMed ID: 19462994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging.
    Opazo F; Krenz A; Heermann S; Schulz JB; Falkenburger BH
    J Neurochem; 2008 Jul; 106(2):529-40. PubMed ID: 18410502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage.
    Lev N; Melamed E; Offen D
    Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time analysis of amyloid fibril formation of alpha-synuclein using a fibrillation-state-specific fluorescent probe of JC-1.
    Lee JH; Lee IH; Choe YJ; Kang S; Kim HY; Gai WP; Hahn JS; Paik SR
    Biochem J; 2009 Mar; 418(2):311-23. PubMed ID: 19007333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.
    Parihar MS; Parihar A; Fujita M; Hashimoto M; Ghafourifar P
    Int J Biochem Cell Biol; 2009 Oct; 41(10):2015-24. PubMed ID: 19460457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization.
    Bosco DA; Fowler DM; Zhang Q; Nieva J; Powers ET; Wentworth P; Lerner RA; Kelly JW
    Nat Chem Biol; 2006 May; 2(5):249-53. PubMed ID: 16565714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised calcium promotes α-synuclein aggregate formation.
    Nath S; Goodwin J; Engelborghs Y; Pountney DL
    Mol Cell Neurosci; 2011 Feb; 46(2):516-26. PubMed ID: 21145971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
    Kong B; Chae Y; Lee K
    Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity.
    Martin BR; Giepmans BN; Adams SR; Tsien RY
    Nat Biotechnol; 2005 Oct; 23(10):1308-14. PubMed ID: 16155565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
    Celej MS; Caarls W; Demchenko AP; Jovin TM
    Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blockade of the aberrant aggregation of alpha-synuclein in HEK293 cells induced by overexpression of wild-type alpha-synuclein by RNA interference].
    Chen T; Tang BS; Liao XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):128-31. PubMed ID: 18393229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
    Kazmierczak A; Strosznajder JB; Adamczyk A
    Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits aggregation of alpha-synuclein.
    Pandey N; Strider J; Nolan WC; Yan SX; Galvin JE
    Acta Neuropathol; 2008 Apr; 115(4):479-89. PubMed ID: 18189141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explorations of the application of cyanine dyes for quantitative alpha-synuclein detection.
    Volkova KD; Kovalska VB; Segers-Nolten GM; Veldhuis G; Subramaniam V; Yarmoluk SM
    Biotech Histochem; 2009 Apr; 84(2):55-61. PubMed ID: 19267288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of membrane interaction and disruption by α-synuclein.
    Reynolds NP; Soragni A; Rabe M; Verdes D; Liverani E; Handschin S; Riek R; Seeger S
    J Am Chem Soc; 2011 Dec; 133(48):19366-75. PubMed ID: 21978222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.